2 ML narsoplimab-wuug 185 MG/ML Injection [Yartemlea]

RxCUI: 2732305
RxNorm name: 2 ML narsoplimab-wuug 185 MG/ML Injection [Yartemlea]
Display name: 2 ML narsoplimab-wuug 185 MG/ML Injection [Yartemlea]
Full name: 2 ML narsoplimab-wuug 185 MG/ML Injection [Yartemlea]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:29

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761152	Yartemlea	narsoplimab-wuug	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
YARTEMLEA	NARSOPLIMAB	Omeros Corporation	f8ff990a-0d2e-433f-9615-b9b097448991	2026-01-20	Warnings, Adverse reactions	Exact identifier rxcui: 2732305

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
f8ff990a-0d2e-433f-9615-b9b097448991	2 ML narsoplimab-wuug 185 MG/ML Injection [Yartemlea]	SBD	6	These highlights do not include all the information needed to use YARTEMLEA safely and effectively. See full prescribing information for YARTEMLEA. YARTEMLEA (narsoplimab-wuug) injection, for intravenous use Initial U.S. Approval: 2025	20260120
f8ff990a-0d2e-433f-9615-b9b097448991	2 ML Yartemlea 185 MG/ML Injection	SY	6	These highlights do not include all the information needed to use YARTEMLEA safely and effectively. See full prescribing information for YARTEMLEA. YARTEMLEA (narsoplimab-wuug) injection, for intravenous use Initial U.S. Approval: 2025	20260120
f8ff990a-0d2e-433f-9615-b9b097448991	YARTEMLEA 370 MG in 2 ML Injection	PSN	6	These highlights do not include all the information needed to use YARTEMLEA safely and effectively. See full prescribing information for YARTEMLEA. YARTEMLEA (narsoplimab-wuug) injection, for intravenous use Initial U.S. Approval: 2025	20260120
f8ff990a-0d2e-433f-9615-b9b097448991	Yartemlea 370 MG per 2 ML Injection	SY	6	These highlights do not include all the information needed to use YARTEMLEA safely and effectively. See full prescribing information for YARTEMLEA. YARTEMLEA (narsoplimab-wuug) injection, for intravenous use Initial U.S. Approval: 2025	20260120